Related Experiment Videos
[Experimental study of postvaccinal immunity to sheep-pox]
Summary
Two live sheep-pox vaccines were developed and tested. The Perego strain vaccine provided reliable immunity and minimal side effects in lambs, outperforming the RM65 strain.
Area of Science:
- Veterinary Virology
- Immunology
Background:
- Sheep-pox is a contagious viral disease affecting sheep worldwide.
- Live virus vaccines are crucial for controlling sheep-pox outbreaks.
Purpose of the Study:
- To develop and compare two live virus sheep-pox vaccines (Perego and RM65 strains) derived from lamb testicular cells.
- To evaluate vaccine safety, immunogenicity, and efficacy against sheep-pox.
Main Methods:
- Vaccine preparation using lamb testicular cells.
- Comparative assessment of safety and activity in lambs against a commercial vaccine.
- Immunogenicity evaluation via antibody detection (neutralizing and precipitating) and challenge resistance using a protective index.
Main Results:
- The Perego vaccine, at 10(4) DICT50, demonstrated reliable immunity with no severe post-inoculation reactions.
- The RM65 vaccine exhibited a lower protective index, only preventing generalized infection.
- A correlation was observed between seroneutralizing titers and protective index, with virulent challenge providing better protection data.
Conclusions:
- The Perego strain live virus sheep-pox vaccine is a promising candidate for reliable sheep-pox control.
- Virulent challenge models appear more effective in assessing vaccine-induced protection levels than serological titers alone.